Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20051
20061
20072
20081
20093
20104
20113
20124
20133
20142
20161
20172
20182
20194
20232
20242
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated11
Active, not recruiting6
Recruiting6
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
AstraZeneca4
Eli Lilly and Company4
GlaxoSmithKline4
Hoffmann-La Roche2
Imperial College London2
Pfizer2
Sanofi2
Takeda2
United Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases49
Stroke11
Myocardial Infarction10
Diabetes Mellitus, Type 29
Atherosclerosis8
Hypertension6
Coronary Disease5
Heart Diseases5
Heart Failure5
Hyperlipidemias5

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.